A significant advance in cancer research is emerging with the use of nanobodies to re-engage mutated p53. This crucial tumor inhibitor protein is frequently inactivated in many forms of cancer, resulting uncontrolled https://bookmarkfox.com/story7672757/vhh-fragments-restore-p53-new-potential-hope-for-cancer-management